Sera Prognostics (SERA) Depreciation & Amortization (CF) (2020 - 2026)
Sera Prognostics (SERA) reported Depreciation & Amortization (CF) of $193000.0 for Q1 2026, down 10.65% on a YoY basis from $216000.0 in Q1 2025, and down 20.9% quarter-over-quarter from $244000.0 in Q4 2025.
Sera Prognostics (SERA) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
Sera Prognostics has reported Depreciation & Amortization (CF) for 7 years, with the latest figure at $193000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 10.65% year-over-year to $193000.0; the trailing twelve-month figure through Mar 2026 stood at $917000.0 (up 10.88% YoY), and the FY2025 full-year result was $940000.0, up 12.85% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $193000.0, down from $244000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $244000.0 in Q4 2025, with the low at $193000.0 in Q1 2026.
- Historically, Depreciation & Amortization (CF) has averaged $211529.4 across 5 years, with a median of $200000.0 in 2022.
- Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) surged 100.0% — and 2024, when it dropped 15.61%.
- Sera Prognostics' Depreciation & Amortization (CF) stood at $203000.0 in 2022, then advanced by 4.43% to $212000.0 in 2023, then declined by 0.47% to $211000.0 in 2024, then grew by 15.64% to $244000.0 in 2025, then declined by 20.9% to $193000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $193000.0 (Q1 2026), $244000.0 (Q4 2025), and $243000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 40.90 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 78.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 67.10 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 123.40 Mn |
| 10 | Sera Prognostics | 100.52 Mn | 100.52 Mn | -28,000.00 | 193,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 193,000.00 |
| Mar 31, 2026 | 193,000.00 |
| Dec 31, 2025 | 244,000.00 |
| Dec 31, 2025 | 244,000.00 |
| Sep 30, 2025 | 243,000.00 |
| Sep 30, 2025 | 243,000.00 |
| Jun 30, 2025 | 237,000.00 |
| Jun 30, 2025 | 237,000.00 |
| Mar 31, 2025 | 216,000.00 |
| Mar 31, 2025 | 216,000.00 |
| Dec 31, 2024 | 211,000.00 |
| Dec 31, 2024 | 211,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Mar 31, 2024 | 200,000.00 |
| Mar 31, 2024 | 200,000.00 |
| Dec 31, 2023 | 212,000.00 |
| Dec 31, 2023 | 212,000.00 |